Qiagen - Halten
WKN: 901626 QIAGEN NVEO -,01 HSBC Trinkaus & Burkhardt 20.07.2000
Qiagen: Genomics collaboration with GCI
(Current/target price: EUR59/EUR50)
Key points
* Collaboration to combine Qiagen’s SNP genotyping services with GCI’s sample repository/database
Commentary The collaboration offers Qiagen access to GCIs sample repertory and database, enabling Qiagen to offer more integrated solutions to its customers in the SNP genotyping area.
Conclusion This is a significant measure on Qiagen’s part to offer integrated solutions to its customers. However, we believe that the current share price already reflects the anticipation of such collaborations by the market. Nevertheless, the share price may show a positive reaction to this announcement
Hold.
gis/tf - © wallstreet-online GmbH
WKN: 901626 QIAGEN NVEO -,01 HSBC Trinkaus & Burkhardt 20.07.2000
Qiagen: Genomics collaboration with GCI
(Current/target price: EUR59/EUR50)
Key points
* Collaboration to combine Qiagen’s SNP genotyping services with GCI’s sample repository/database
Commentary The collaboration offers Qiagen access to GCIs sample repertory and database, enabling Qiagen to offer more integrated solutions to its customers in the SNP genotyping area.
Conclusion This is a significant measure on Qiagen’s part to offer integrated solutions to its customers. However, we believe that the current share price already reflects the anticipation of such collaborations by the market. Nevertheless, the share price may show a positive reaction to this announcement
Hold.
gis/tf - © wallstreet-online GmbH